Answers are grounded in this paper and cite their sources.
In the last 3 decades, geriatric practice has undergone several transformations.1, 2 Its identity has vacillated between a specialty and primary care and between a field of its own and a knowledge area to be applied to other clinical disciplines through “gerontolizing.”3 Geriatrics has defined its traditional roles in the care of older persons exceedingly well, including assessing functional capacities, managing manifestations of chronic diseases, limiting iatrogenic complications, and curtailing invasive (“high-tech”) interventions and procedures where their benefits may be problematic.4 These precepts have been included in geriatrics-specific competencies that all graduating medical students should know “to keep granny safe on July 1”5 or applied imaginatively in the setting of the Hospital-at-Home as an alternative to in-hospital care to improve health outcomes during an acute illness.6 Nevertheless, concerns have been widely expressed about the future of geriatrics in the academic environment. Leaders in the field have noted that, despite the advancing tide of older persons, there is a “dramatic decline in the numbers of geriatricians entering the field”4 and that geriatrics “continues to struggle with its identity, its mission, and its very survival.”7 Integrating the clinical processes of aging into geriatric practice would add an additional dimension. It would encourage early therapeutic interventions to improve health outcomes and raise the awareness of geriatricians about basic aging mechanisms8 and the “new biology of aging”9 that are linked to the emergence of chronic diseases.10 As I noted earlier1, 2 and as Fried and Hall have recently discussed in depth, aging as an additional orientation for geriatric practice would encourage a “partnership and synergy with other primary care providers for a continuum of care that can be deployed to optimize health of patients at different stages of their life course.”11 An understanding of inevitable functional aging changes and their “transitions” over time that can be expressed clinically as disease offers the potential for healthcare providers to limit late-life expression of these chronic diseases in their patients over a wide age range. Table 1 lists a number of functional changes of aging and their transitions that can progress to disease. These are some examples of early interventions that could delay or reduce disease expression later in life: identifying the potential for accelerated bone loss in women with a family history of a maternal fracture, early menopause, smoking, and a diet deficient in vitamin D and calcium, among other risk factors, that could prompt interventions to limit the occurrence of a first Colles fracture or, more ominously, an often undetected vertebral fracture12 detecting early signs consistent with frailty, including apathy, lack of socialization, anorexia, weight loss, and weakness with decreased muscle strength (sarcopenia), that put these pre-frail persons at risk for further decline by virtue of loss of mobility, falls, institutionalization, and even death13 but where there is “ample opportunity for prevention and remediation of frailty”14 noting increasing abdominal girth associated with visceral adiposity that predisposes to the development of insulin resistance, hypertension, hyperlipidemia, and atherosclerotic complications—aspects of the metabolic syndrome for which diet and medications may be used to limit progression15 observing early signs of cognitive decline that may, in follow-up, deviate from aging changes and be suggestive of the emergence of Alzheimer's disease A number of molecular and metabolic changes observed in the brain in Alzheimer's disease16—such as mitochondrial dysfunction, oxidative stress, disturbances in the insulin signaling pathway, and inflammation, among other findings, are consistent with classically described basic aging mechanisms.8 Thus “it remains possible that many of the mechanisms discussed in the etiology of Alzheimer's disease, including the amyloid hypothesis, are minor or wrong, and that some critical aging-related process is the disease trigger.”16 Understanding the inception of these changes may mean new approaches to therapeutic interventions earlier. Geriatricians and other primary providers need to be aware of research by biogerontologists on aging animal models in the laboratory. Using genetic, metabolic, and dietary interventions, biogerontologists have “at long last found something useful to do”—extending longevity in these animal models that then show fewer signs of disease “at the time of their dramatically postponed death.”17 If “the implication of these findings is that protection against ageing processes results in protection against diverse, ageing-related diseases,”9 then the potential for application to human beings becomes an important goal as part of the provision of health care. In one recent relevant study, a pharmacological approach to extend a healthy life span in aged mice was achieved with rapamycin, which inhibits the target-of-rapamycin-signaling pathway.18 Geriatricians can also work with biogerontologists to “identify priorities and strategies to ‘reverse translate’ critical aspects of human aging into appropriate analogous animal phenotypes. Key to this endeavor would be to have the animal models reflect consensus on human functional aging. The collection of these traits might then represent what it means to have success along the continuum of health with age, that is, a lengthy health span.”19 Aging and basic aging mechanisms are the appropriate and broader dimension for geriatricians to observe in their associations with other primary care providers and in their collaboration with biogerontologists. Geriatrics has the prospect of shifting from “what was viewed as laudable but rather futile efforts to palliate the misery of those in the process of dying to becoming a more attractive and increasingly important specialty.”20 The interactions and directions proposed here are part of that shift and have the potential to promote health outcomes that may ultimately benefit our healthcare system and best serve the aspirations of an aging American society seeking to “live well until 100.”21 Conflict of Interest: The editor in chief has reviewed the conflict of interest checklist provided by the author and has determined that the author has no financial or any other kind of personal conflicts with this paper. Author Contribution: Sole author. Sponsor's Role: None.
No takes yet. Share an insight, caveat, or question.
David Hamerman (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: